Clinical Trials Directory

Trials / Completed

CompletedNCT00893919

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Roxane Laboratories · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to prove the bioequivalence of Mycophenolate Mofetil 250 mg Capsules under fed conditions.

Conditions

Interventions

TypeNameDescription
DRUGmycophenolate mofetilmycophenolate mofetil 250 mg capsule

Timeline

Start date
2005-11-01
Primary completion
2005-11-01
Completion
2005-11-01
First posted
2009-05-06
Last updated
2018-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00893919. Inclusion in this directory is not an endorsement.